Table 3.
Variables | Healthy Control Subjects | No. of Patients (%) |
p Value | |
---|---|---|---|---|
miR-491 Low (n = 58) | miR-491 High (n = 44) | |||
Gender | 0.50 | |||
Male | 8 | 32 (55.17) | 22 (50.00) | |
Female | 12 | 26 (44.83) | 22 (50.00) | |
Age | ||||
Median | 24.5 | 17.3 | 16.4 | |
Range | 7–43 | 4–41 | 4–40 | |
Anatomical site | 0.88 | |||
Femur | 29 (50.00) | 23 (52.27) | ||
Tibia | 13 (22.41) | 12 (27.27) | ||
Humerus | 12 (20.69) | 6 (13.64) | ||
Pelvis | 2 (3.45) | 1 (2.27) | ||
Other | 2 (3.45) | 2 (4.55) | ||
Histologic subtype | 0.63 | |||
Osteoblastic | 33 (56.90) | 27 (61.36) | ||
Chondroblastic | 7 (12.07) | 6 (13.64) | ||
Fibroblastic | 13 (22.41) | 5 (11.36) | ||
Telangiectatic | 3 (5.17) | 3 (6.82) | ||
Other | 2 (3.45) | 3 (6.82) | ||
Histologic grade | 0.18 | |||
III | 8 (13.79) | 2 (4.55) | ||
IV | 50 (86.21) | 42 (95.45) | ||
Enneking grade | 0.77 | |||
2A | 9 (15.52) | 5 (11.36) | ||
2B | 49 (84.48) | 39 (88.64) |